Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep780 | Obesity | ECE2016

Glucose and insulin up-regulate the cardiovascular biomarker GDF15 in vivo and in vitro: effect of meal content and obesity

Schernthaner-Reiter Marie Helene , Kasses Dominik , Tugendsam Christina , Riedl Michaela , Peric Slobodan , Clodi Martin , Luger Anton , Vila Greisa

Introduction: Growth differentiation factor 15 (GDF15) has recently been characterized as a cardiovascular risk factor. GDF15 correlates with insulin resistance and obesity in cross-sectional studies and exerts anorexigenic effects in interventional rodent studies. GDF15 has been proposed as a possible therapeutic target in the treatment of obesity, however its meal- and nutrient-dependent regulation in humans has not been investigated previously.Methods...

ea0037ep212 | Reproduction, endocrine disruptors and signalling | ECE2015

XbaI and PvuII oestrogen receptor alpha gene polymorphism and Y chromosome deletions in infertile vs fertile men

Vladoiu Suzana , Dinu Dana , Anton Gabriela , Botezatu Anca , Manda Dana , Oros Sabina , Ianas Olga , Paun Diana , Badiu Corin , Rosca Roxana

Only a few genes involved in spermatogenesis have clinical importance: Y chromosome micro deletions in the region called azoospermia factor (AZF) and oestrogen receptor alpha gene polymorphisms (ESR1).Objective: The study aim to evaluate ESR1 and Y chromosome deletion in infertile men.Subjects and methods: 43 infertile men, and 34 fertile men aged 20–50 years 50, were enrolled after signing the informed consent. Screening for ...

ea0037ep742 | Pituitary: clinical | ECE2015

Tumour regrowth in growth hormone deficient adults with non-functioning pituitary adenomas using growth hormone replacement therapy – a sub-analysis from the Dutch National Registry of growth hormone treatment in Adults

van Varsseveld Nadege , van Bunderen Christa , Franken Anton , Koppeschaar Hans , van der Lely Aart Jan , Drent Madeleine

Objective: Growth hormone treatment (GHT) is a widely accepted treatment in growth hormone deficient (GHD) adults with nonfunctioning pituitary adenoma (NFPAs). However, concerns remain about the safety of GHT, because of its potentially stimulating effect on tumour (re)growth. The aim of this study was to evaluate tumour progression in NFPA patients using GHT.Patients and methods: From the Dutch National Registry of growth hormone treatment in adults, a...

ea0037ep1343 | Clinical Cases–Thyroid/Other | ECE2015

Concomitance of pancreatic and neuroendocrine breast tumour – simple coincidence or not?

Crumpei Iulia , Fadur Alina , Manolachie Adina , Zmau George , Anton Mihaela , Volovat Constantin , Ungureanu Maria Christina , Vulpoi Carmen

Introduction: Breast neuroendocrine carcinoma is a rare aggressive neuroendocrine tumour (NET) and the research on this subject is poor. Only seven studies were cited in the literature. Incidence in the population has not been reported, but the prevalence is under 0.1% of all breast carcinomas.Case report: AV, 72, is hospitalised for bone pain and significant weight loss (15 kg in 2 months). Patient’s previous history are: diabetes, hypertension, no...

ea0035p129 | Calcium and Vitamin D metabolism | ECE2014

Cardio-metabolic phenotyping of patients with familiar hypocalciuric hypercalcemia

Wolf Peter , Krssak Martin , Winhofer Yvonne , Anderwald Christian , Zwettler Elisabeth , Trattnig Siegfried , Luger Anton , Baumgartner-Parzer Sabina , Krebs Michael

Introduction: Heterozygous inactivating mutations of the calcium sensing receptor (CaSR) gene cause mild alterations in calcium metabolism (familiar hypocalciuric hypercalcemia (FHH)). However, in addition to the parathyroid gland CaSR expression was recently identified in the myocardium and many other endocrine cells including pancreatic islet cells, entero-endocine cells and adipose tissue. So far, it is unknown whether FHH is associated with cardio-metabolic altera...

ea0070ep341 | Pituitary and Neuroendocrinology | ECE2020

Long-term-follow-up of patients with gastric bypass surgery secondary to craniopharyngioma associated hypothalamic obesity

Beiglböck Hannes , Fellinger Paul , Ranzenberger-Haider Tamara , Vila Greisa , Luger Anton , Kautzky-Willer Alexandra , Krebs Michael , Wolf Peter

Background: Patients being cured of craniopharyngioma (CP) often suffer from severe hypothalamic obesity due to tumor localization or therapeutic interventions, which has a major impact on increased mortality and reduced quality of life. Gastric bypass surgery (GBS) was suggested to be an effective therapeutic option for weight reduction in those patients. However, long-term changes in body weight and postsurgical complications are unknown.Methods: 5 pat...

ea0022oc3.1 | Pituitary | ECE2010

Sgk1 effects on POMC transcription and ACTH release are opposite to those of glucocorticoids

Reiter Marie Helene , Vila Greisa , Baumgartner-Parzer Sabina M , Knosp Engelbert , Wagner Ludwig , Stalla Gunter K , Luger Anton

Glucocorticoid feed-back in pituitary corticotrophs represses POMC transcription and ACTH release. Serum and glucocorticoid-induced kinase 1 (Sgk1) has been identified as an immediate early target of glucocorticoids in many tissues, however its expression and function in corticotrophs are unknown.We show here that Sgk1 is present in the human pituitary gland at both mRNA and protein levels. Double-immunohistochemistry revealed that Sgk1 is expressed in d...

ea0022p714 | Obesity | ECE2010

Effects of breastfeeding on maternal appetite-regulating hormones

Vila Greisa , Hopfgartner Judith , Grimm Gabriele , Riedl Michaela , Baumgartner-Parzer Sabina , Kautzky-Willer Alexandra , Clodi Martin , Luger Anton

Gestational weight gain has been linked to obesity in women of childbearing age. Mothers who breastfeed present less postpartum weight retention. The underlying pathophysiological mechanisms are unknown. This study aimed at investigating the impact of breastfeeding on maternal appetite-regulating hormones.The clinical trial recruited 29 women divided in three age- and BMI-matched groups. The first group included 10 fully breastfeeding mothers of 3 to 6 m...

ea0020p213 | Endocrine tumours and neoplasia | ECE2009

Image-guided radioiodine therapy of HCC following AFP-promoter targeted in vivo sodium iodide symporter (NIS) gene transfer

Klutz Katrin , Willhauck Michael J , Wunderlich Nathalie , Zach Christian , Senekowitsch-Schmidtke Reingard , Anton Martina , Goke Burkhard , Spitzweg Christine

Due to limited treatment options the prognosis of patients with advanced hepatocellular cancer (HCC) has remained poor. We therefore examined the feasibility of radioiodine therapy of HCC after human sodium iodide symporter (hNIS) gene transfer, using the tumor-specific alpha-fetoprotein (AFP) promoter for transcriptional targeting. For this purpose NIS gene transfer was performed in vivo in human HCC cell (HepG2) xenografts, using replication-deficient adenoviral vecto...

ea0020p546 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

The prevalence of diabetes mellitus in 9776 adult patients with childhood- and adult-onset growth hormone (GH) deficiency before GH replacement: a KIMS analysis

Abs Roger , Luger Anton , Wilton Patrick , Thunander Maria , Verhelst Johan , Goth Miklos , Koltowska-Haggstrom Maria , Mattsson Anders

Background: Untreated GH-deficiency (GHD) in adults has been suggested to be associated with an increased prevalence of type 2 diabetes mellitus (DM). Proposed causative factors are the tendency to overweight and the insulin resistance due to central adiposity.Patients and methods: The KIMS (Pfizer International Metabolic Database) was used to evaluate the prevalence of DM in both childhood-onset (CO; n=1977; 56% males) and in adult-onset (AO; ...